We at Receptor.AI are excited to present the next important milestone in the development of our next-generation AI docking model, …
Jan. 17, 2024
Veeva Systems, a prominent player in cloud-based software for the global life sciences industry, has successfully migrated a significant portfolio …
Jan. 15, 2024
Mesenbio, a pioneering biotechnology firm emerging from the University of York, has recently secured a significant £1.4 million investment. This …
Jan. 12, 2024
In 2023, the venture capital (VC) landscape witnessed significant activity, providing crucial support to the biotech sector amidst a volatile …
Jan. 12, 2024
I always think of the Jeff Goldblum quote in Jurassic Park where he says "life finds a way" when I …
Jan. 12, 2024
We are witnessing a revolution in cancer therapeutics that is truly bewildering. The number of novel drugs with unique mechanisms …
Jan. 12, 2024
In the incredibly competitive world of drug development, comprehensive precision, and healthtech, every strategic control point is essential. Over the …
Jan. 12, 2024
In 1945 the volume of human knowledge doubled every 25 years. Now, that number is 12 hours [1]. With our …
Jan. 12, 2024
Chapter 1 of a 3-chapter Hitchhiker’s guide to cell-free DNA for travelers of all backgrounds and expertise. Even though I’ve …
Jan. 12, 2024
Chapter 2 of a Hitchhiker's Guide to Cell-Free DNA. By the end of 2022, there will be an estimated 609,360 …
Jan. 12, 2024
Advances in computational biology, precision medicine, artificial intelligence/machine learning, etc., are launching us into a world where strategic control points …
Jan. 12, 2024
Verge Genomics, a clinical-stage biotechnology company, has just initiated a Phase 1b proof-of-concept study for VRG50635, a drug developed for …
